SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-14-003319
Filing Date
2014-08-07
Accepted
2014-08-07 16:17:03
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q dvax-10q_20140630.htm 10-Q 1592107
2 EX-31.1 dvax-ex31_2014063029.htm EX-31 17263
3 EX-31.2 dvax-ex31_2014063030.htm EX-31 17292
4 EX-32.1 dvax-ex32_2014063031.htm EX-32 9074
5 EX-32.2 dvax-ex32_2014063032.htm EX-32 9054
  Complete submission text file 0001564590-14-003319.txt   7374856

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dvax-20140630.xml EX-101.INS 1202583
7 XBRL TAXONOMY EXTENSION SCHEMA dvax-20140630.xsd EX-101.SCH 33101
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dvax-20140630_cal.xml EX-101.CAL 43503
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dvax-20140630_def.xml EX-101.DEF 239593
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dvax-20140630_lab.xml EX-101.LAB 317151
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dvax-20140630_pre.xml EX-101.PRE 275879
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34207 | Film No.: 141024137
SIC: 2834 Pharmaceutical Preparations